StaphOff has developed a completely unique approach to fighting staphylococcal infections using a first-in-class heptapeptide known as RNAIII Inhibiting Peptide (RIP) or CEN-101, and non-peptide analogues like CEN-103.
Latigo Biotherapeutics
1 follower
Thermo Fisher Scientific
286 followers
Genentech
226 followers
Gilead Sciences
214 followers
Regeneron
183 followers
Biogen
166 followers
Vertex Pharmaceuticals
111 followers
Agilent Technologies
101 followers
Illumina
93 followers
BioMarin Pharmaceutical
59 followers
Alexion Pharmaceuticals
56 followers
Myriad Genetics
42 followers